Azafaros Strengthens Leadership Team With Appointment of Amy Sullivan as Chief Financial Officer

Contributed by: Business Wire

Tags

Health

Neurology

Other Science

Research

Science

Pharmaceutical

Biotechnology

Amy Sullivan

More Like This

Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders

Azafaros to Present at BIO International Convention 2025 Following Successful €132M Series B Financing

Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference

Azafaros to Present at J.P. Morgan’s 43rd Annual Healthcare Conference

Azafaros Announces Key Scientific Oral and Poster Presentations on Nizubaglustat Accepted for WORLDSymposium™ 2026

Azafaros granted important regulatory designations and clearance by European authorities for global Phase 3 studies, to be initiated in 2025

Azafaros Announces Key Scientific Oral and Poster Presentations on Nizubaglustat Accepted for WORLDSymposium™ 2025

Azafaros Announces Publication of Preclinical Efficacy Data with Nizubaglustat in GM2 Gangliosidosis